# Enveric Biosciences, Inc.: Form DEF 14A, filed Sep 18, 2023

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: DEF 14A
- Filed: 2023-09-18
- Accepted by EDGAR: Sep 18, 2023, 16:50 ET
- Period: 2023-09-18
- Accession: 0001493152-23-032930
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000149315223032930/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000149315223032930/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000149315223032930/formdef14a.htm

Filed Sep 18, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-032930. Last ingested by Listed: Nov 3, 2026, 18:51 ET. No prices; not investment advice.